Convergence Science are holding a panel discussion on the challenges facing biomedical research in Melbourne.
The panel will discuss:
- What do future funding scenarios for biomedical research mean (including recent changes to the National Health and Medical Research Council’s grant program)?
- What new approaches do we need to help our young researchers as they attempt to build a viable career in biomedical research?
- How will we translate more of our biomedical research into clinical, commercial and economic success?
- What does the research community need to do in order continue to win, and hold, the public’s trust?
- How do we transform public support in to political action?
Members of the panel include:
- Professor Anne Kelso AO – CEO of the National Health and Medical Research Council (NHMRC);
- Sir Gustav Nossal AC CBE – internationally recognised adviser on global health and former Director of the Walter & Eliza Hall Institute (WEHI);
- Professor John Carroll – Director of the Monash Biomedicine Discovery Institute.
- Professor Darren Kelly – CEO & Managing Director, OccuRx, Associate Dean (Innovation and Commercialisation) Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Director Biomedical Research, St Vincent’s Hospital.
- Dr Sarah Meachem – researcher at the Hudson Institute and former Director of the Australian Society for Medical Research, and
- Dr Rachel Nowak – Associate Director, Research, Innovation and Commercialisation, The University of Melbourne (Master of Ceremonies)
For more details and registration head to http://www.convergencesciencenetwork.org.au/convergence-science-forum-events.html#event2.
What: Convergence Science Forum: Challenges Facing Biomedical Research
When: 18:00 – 19:30, 14 August, 2017
Where: Clarendon Auditorium, Level 2, Melbourne Exhibition Centre, 2 Clarendon Street, South Wharf